Treatment strategy in depression: I. Non‐tricyclic and selective reuptake inhibitors in resistant depression: a double‐blind partial crossover study on the effects of oxaprotiline and fluvoxamine
The DOI matches its Crossref record.
Abstract
Antidepressants are ineffective in about 30% of patients with major depression. Some authors then advise treatment of non‐responders with (non‐tricyclic) more selective reuptake inhibitors. In a double‐blind, partial crossover study, 71 patients were selected for treatment during 4 weeks with oxaprotiline and/or fluvoxamine, two non‐tricyclic antidepressants that are selective reuptake inhibitors of noradrenaline and serotonin respectively. All patients had failed to respond to earlier treatment with cyclic antidepressants during the current episode. Only 13% of the patients responded, with 27% of them responding to oxaprotiline and none to fluvoxamine. Moreover, a low response of 27% was also obtained in the crossover phase, which included all non‐responders to the first treatment, oxaprotiline being effective in 39% and fluvoxamine in 10% of the patients. The results indicate that selective reuptake inhibitors are not an effective alternative for non‐responders to other cyclic antidepressants and that non‐responders to “nor‐adrenergic” antidepressants do not appear to have much chance of responding to “serotonergic” antidepressants and vice versa.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Bupropion-SR, Sertraline, or Venlafaxine-XR after Failure of SSRIs for Depression
Rush, A. J., Trivedi, M. H., Wisniewski, S. R., Stewart, J. W., Nierenberg, A. A., Thase, M. E., Ritz, L., Biggs, M. M., Warden, D., Luther, J. F., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa052963 · Cited by 1,033
Anderson, I., Ferrier, I., Baldwin, R., Cowen, P., Howard, L., Lewis, G., Matthews, K., McAllister-Williams, R., Peveler, R., Scott, J., et al. (2008) · Journal of Psychopharmacology · doi:10.1177/0269881107088441 · Cited by 908
(2007) · PubMed · Cited by 453
Treatment resistant depression: methodological overview and operational criteria
Souery, D., Amsterdam, J., de Montigny, C., Lecrubier, Y., Montgomery, S., Lipp, O., Racagni, G., Zohar, J., & Mendlewicz, J. (1999) · European Neuropsychopharmacology · doi:10.1016/s0924-977x(98)00004-2 · Cited by 444
Serotonin a la carte: Supplementation with the serotonin precursor 5-hydroxytryptophan
Turner, E. H., Loftis, J. M., & Blackwell, A. D. (2006) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2005.06.004 · Cited by 326
Metadata
- Authors
- Nolen, W. A., Putte, J. J. V. D., Dijken, W. A., Kamp, J. S., Blansjaar, B. A., Kramer, H. J., & Haffmans, J.
- Venue
- Acta Psychiatrica Scandinavica
- Publisher
- Wiley
- Published
- 1988-12
- Volume
- 78
- Issue
- 6
- Pages
- 668-675
- ISSN
- 0001-690X (ISSN-L)
- 1600-0447
- OpenAlex
- W1933790375
- Cited by
- 74
- References
- 0
- FWCI
- 2.66
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Treatment strategy in depression: I. Non‐tricyclic and selective reuptake inhibitors in resistant depression: a double‐blind partial crossover study on the effects of oxaprotiline and fluvoxamine. https://app.cochat.ai/papers/10.1111/j.1600-0447.1988.tb06402.x
- The paper
- Nolen, W. A., Putte, J. J. V. D., Dijken, W. A., Kamp, J. S., Blansjaar, B. A., Kramer, H. J., & Haffmans, J. (1988). Treatment strategy in depression: I. Non‐tricyclic and selective reuptake inhibitors in resistant depression: a double‐blind partial crossover study on the effects of oxaprotiline and fluvoxamine. Acta Psychiatrica Scandinavica. https://doi.org/10.1111/j.1600-0447.1988.tb06402.x
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.